Next Article in Journal
Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care
Next Article in Special Issue
Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers
Previous Article in Journal
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Previous Article in Special Issue
Smart Modification on Magnetic Nanoparticles Dramatically Enhances Their Therapeutic Properties
 
 
Article
Peer-Review Record

Ag/Au Bimetallic Nanoparticles Trigger Different Cell Death Pathways and Affect Damage Associated Molecular Pattern Release in Human Cell Lines

Cancers 2022, 14(6), 1546; https://doi.org/10.3390/cancers14061546
by Hector Katifelis 1, Maria-Paraskevi Nikou 1, Iuliia Mukha 2, Nadiia Vityuk 2, Nefeli Lagopati 3,4, Christina Piperi 5, Ammad Ahmad Farooqi 6, Natassa Pippa 7, Efstathios P. Efstathopoulos 8,9 and Maria Gazouli 1,8,9,*
Reviewer 1:
Reviewer 2: Anonymous
Cancers 2022, 14(6), 1546; https://doi.org/10.3390/cancers14061546
Submission received: 21 February 2022 / Revised: 10 March 2022 / Accepted: 17 March 2022 / Published: 17 March 2022
(This article belongs to the Special Issue Cancer Smart Nanomedicine)

Round 1

Reviewer 1 Report

Please see attachment

Comments for author File: Comments.docx

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

The article “Ag/Au bimetallic nanoparticles trigger different cell death pathways and affect Damage Associated Molecular Patterns release in human cell lines”, submitted to Cancers, addresses the induction of apoptosis, necrosis, or pyroptosis in different cancer cell lines after the treatment with AgAu NPs, Ag NPs, and Au NPs. The authors claim that NPs possess strong cytotoxic activity and trigger different types of programmed cell death in breast, prostate, and colorectal cancer. However, some points need to be clarified.

  1. The article addresses the investigation of types of programmed cell death, triggered with AgAu NPs, Ag NPs and Au NPs. However, conclusions about the apoptosis induction are made based only on the caspase-3 expression, which is not enough. It was a good idea to add IL-1b investigation to the previous article version to investigate pyroptosis. Additional tests, such as Annexin V/Propidium iodide staining to determine apoptosis/ necrosis would strengthen the conclusions about the type of triggered cell death.
  2. The statements added to the "conclusion" section are questionable. Why do the authors claim that  "IL-1β levels could have a role in the prediction of response to pyroptosis-inducing treatments"? In the current investigation IL-1β was used as a pyroptosis marker to determine the type of programmed cell death. To conclude about its prognostic value some in vivo studies should be performed with calculating correlations between viability/ dynamics of tumor growth and the IL-1β  levels. Same question arises regarding HMGB1, which was used initially as the evidence of DAMP release, but the conclusion is made vise verse about its prognostic value. So, cause and effect relationships need to be clarified

Minor comment:

Figure 6 should be centered related to the text.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

Authors made considerable job in collecting a lot of data. I believe that this can be of some use in the future researches. I wish the authors all the best and hope that they will plan their future articles more thoroughly, especially graphical content. 

Reviewer 2 Report

Dear authors,

I am sorry to hear that your colleagues were impacted by the events in Ukraine. I suppose that the addition of data about the downregulation of Bcl-2 gene expression provides a good confirmation of apoptosis induction. The article now can be accepted.

Back to TopTop